← All organizations

Australian Respiratory and Sleep Medicine Institute

Academic/Hospital

Also known as: ARASMI | Australian Respiratory and Sleep Medicine Institute | Australian Respiratory and Sleep Medicine Institute Ltd

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

May 1, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (7 distinct, 8 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

hepadvax

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (13)

NCT06355232OfficialPhase 1May 1, 2024
NCT06355232CollaboratorPhase 1May 1, 2024
NCT05807035CollaboratorPhase 1Feb 10, 2023
NCT05807035Overall official - principal investigatorPhase 1Feb 10, 2023
NCT05542862CollaboratorPhase 3Sep 7, 2022
NCT05542862Overall official - principal investigatorPhase 3Sep 7, 2022
NCT05279456CollaboratorPhase 3Aug 15, 2022
NCT05279456Study directorPhase 3Aug 15, 2022
NCT05148871Overall official - principal investigatorPhase 2/Phase 3Dec 31, 2021
NCT05148871CollaboratorPhase 2/Phase 3Dec 31, 2021
NCT03038802CollaboratorPhase 1/Phase 2Jun 1, 2017
NCT03038776CollaboratorPhase 1Jan 1, 2017
NCT02335164CollaboratorPhase 1Jul 1, 2015

Details

Last known activity: May 1, 2024